Finance

Lists
Q3 2026 earnings • in 5 days
See details
GDRX:NASDAQ
Goodrx Holdings Inc
US$3.55
+1.14%
(+0.040) 1D
ኖቬም 13, 10:24:12 ጥዋት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GDRX...
Open
US$3.56
High
US$3.60
Low
US$3.54
Mkt. cap
1.21 ቢ
Avg. vol.
1.08 ሚ
Volume
107.79 ሺ
P/E ratio
75.61
52-wk high
US$3.88
52-wk low
US$1.77
EPS
US$0.05
Beta
1.66
Shares outstanding
107.18 ሚ
No. of employees
697
Open
US$3.56
High
US$3.60
Low
US$3.54
Mkt. cap
1.21 ቢ
Avg. vol.
1.08 ሚ
Volume
107.79 ሺ
P/E ratio
75.61
52-wk high
US$3.88
52-wk low
US$1.77
EPS
US$0.05
Beta
1.66
Shares outstanding
107.18 ሚ
No. of employees
697
News stories
From web sources and news partners
About Goodrx Holdings Inc
CEO-
Employees697
Founded2011
HeadquartersSanta Monica, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitegoodrx.com
Analyst ratings
Based on 3 analysts giving stock ratings to GDRX in the past 3 months
Sell
Buy
0
Hold
1
Sell
2
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for GDRX in the last 3 months.
Highest
Current US$3.55
US$4.00 (+12.68%)
Average
US$3.33 (-6.20%)
Lowest
US$2.65 (-25.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Sell
Maintained
US$2.65
-25.4%
09/15/2026
Glen Santangelo
Barclays
Sell
Maintained
US$4.00
+12.7%
08/20/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
-
-
08/14/2026
Kevin Caliendo
UBS
Hold
Maintained
US$3.75
+5.6%
08/13/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
US$5.00
+40.8%
08/11/2026
Daniel Grosslight
Citi
Buy
Maintained
US$5.00
+40.8%
08/11/2026
Parker Snure
Raymond James
Buy
Maintained
US$4.50
+26.8%
08/07/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
US$4.00
+12.7%
08/07/2026
Eric Sheridan
Goldman Sachs
Hold
Reiterated
US$4.00
+12.7%
08/07/2026
Michael Cherny
Leerink Partners
Buy
Maintained
US$5.00
+40.8%
08/06/2026
Stan Berenshteyn
Wells Fargo
Buy
Maintained
US$3.50
-1.4%
06/02/2026
George Hill
Deutsche Bank
Hold
Maintained
US$3.00
-15.5%
02/27/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
US$3.00
-15.5%
02/27/2026
Lisa Gill
J.P. Morgan
Hold
Downgraded
-
-
02/26/2026
Next call በ5 ቀናት ውስጥ
ረቡዕ፣ ኖቬም 18, 3:00 ከሰዓት
Fiscal period
Q3 2026
- / US$0.08
Revenue / Est. (USD)
- / 202.09 ሚ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
196.03 ሚ
194.78 ሚ
194.01 ሚ
200.41 ሚ
Cost of goods sold
13.42 ሚ
17.46 ሚ
20.16 ሚ
21.00 ሚ
Cost of revenue
13.42 ሚ
17.46 ሚ
20.16 ሚ
21.00 ሚ
Research and development expenses
31.01 ሚ
25.24 ሚ
30.18 ሚ
26.71 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
115.55 ሚ
91.96 ሚ
107.87 ሚ
106.80 ሚ
Operating expense
167.99 ሚ
140.34 ሚ
159.84 ሚ
155.78 ሚ
Total operating expenses
181.41 ሚ
157.81 ሚ
180.00 ሚ
176.78 ሚ
Operating income
14.62 ሚ
36.98 ሚ
14.01 ሚ
23.63 ሚ
Other non operating income
-
24.00 ሺ
-
625.00 ሺ
EBT including unusual items
6.10 ሚ
14.19 ሚ
5.64 ሚ
15.47 ሚ
EBT excluding unusual items
6.10 ሚ
28.49 ሚ
5.64 ሚ
15.47 ሚ
Income tax expense
4.98 ሚ
8.77 ሚ
4.47 ሚ
6.93 ሚ
Effective tax rate
81.66%
61.78%
79.27%
44.81%
Other operating expenses
-
-
-
-
Net income
1.12 ሚ
5.42 ሚ
1.17 ሚ
8.54 ሚ
Net profit margin
0.57%
2.79%
0.60%
4.26%
Earnings per share
0.08
0.09
0.07
0.08
Interest and investment income
2.31 ሚ
1.89 ሚ
1.40 ሚ
1.02 ሚ
Interest expense
-10.83 ሚ
-10.40 ሚ
-9.77 ሚ
-9.81 ሚ
Net interest expenses
-8.52 ሚ
-8.51 ሚ
-8.37 ሚ
-8.79 ሚ
Depreciation and amortization charges
21.43 ሚ
23.15 ሚ
21.79 ሚ
22.27 ሚ
EBITDA
36.05 ሚ
60.12 ሚ
35.80 ሚ
45.90 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች